{{Rsnum
|rsid=3774937
|Gene=NFKB1
|Chromosome=4
|position=102513096
|Orientation=plus
|GMAF=0.292
|Gene_s=NFKB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 54.0 | 38.9
| HCB | 8.8 | 51.8 | 39.4
| JPT | 14.2 | 39.8 | 46.0
| YRI | 0.0 | 1.4 | 98.6
| ASW | 1.8 | 17.5 | 80.7
| CHB | 8.8 | 51.8 | 39.4
| CHD | 11.0 | 43.1 | 45.9
| GIH | 10.9 | 35.6 | 53.5
| LWK | 0.0 | 0.9 | 99.1
| MEX | 24.1 | 44.8 | 31.0
| MKK | 0.0 | 12.8 | 87.2
| TSI | 4.0 | 45.5 | 50.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23153769
|Title=Impact of NF-κB gene polymorphism on allograft outcome in Hispanic renal transplant recipients
}}

{{PMID Auto
|PMID=19223558
|Title=Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}